Results 151 to 160 of about 944,744 (294)

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Nature Genetics, 2019
R. Samstein, Chung-Han Lee, A. Shoushtari, M. Hellmann, R. Shen, Y. Janjigian, D. Barron, A. Zehir, E. Jordan, A. Omuro, T. Kaley, S. Kendall, R. Motzer, A. Hakimi, M. Voss, P. Russo, J. Rosenberg, G. Iyer, B. Bochner, D. Bajorin, H. Al-Ahmadie, J. Chaft, C. Rudin, Gregory Riely, S. Baxi, A. Ho, R. Wong, D. Pfister, J. Wolchok, C. Barker, P. Gutin, C. Brennan, V. Tabar, I. Mellinghoff, L. Deangelis, C. Ariyan, N. Lee, W. Tap, M. Gounder, S. D’Angelo, L. Saltz, Z. Stadler, H. Scher, J. Baselga, P. Razavi, C. Klebanoff, R. Yaeger, N. Segal, G. Ku, R. DeMatteo, M. Ladanyi, N. Rizvi, M. Berger, N. Riaz, D. Solit, T. Chan, L. Morris   +56 more
semanticscholar   +1 more source

Humphrey Center News: Spring/Summer 1986 v. 2, no. 2 [PDF]

, 1986
Newsletter of the Hubert H.
Beldekas, John C., Black, Paul H., Hubert H. Humphrey Cancer Research Center of Boston University, Levy, Elinor M.   +3 more
core  

The role of the immune system in brain metastasis [PDF]

, 2019
Metastatic brain tumors are the most common brain tumors in adults. With numerous successful advancements in systemic treatment of most common cancer types, brain metastasis is becoming increasingly important in the overall prognosis of cancer patients ...
Dey, Mahua, Leibold, Adam T., Monaco, Gina N.   +2 more
core  

TGF-β Decreases NK Cell Mobility and Cytotoxic Efficacy in Complex in vitro Models of the Leukemia Microenvironment

ImmunoTargets and Therapy
Veronika Švubová,1,2 Lucie Janstová,1 Marek Jedlička,1,2 Eva Mašínová,1,2 Jana Szabová,1 Tereza Feglarová,1 Kateřina Kuglerová,1 Veronika Bosáková,3,4 Barbora Brodská,1 Kristýna Boráková,5 David Kundrát,1 Iva Trsová,1,6 Martina ...
Švubová V, Janstová L, Jedlička M, Mašínová E, Szabová J, Feglarová T, Kuglerová K, Bosáková V, Brodská B, Boráková K, Kundrát D, Trsová I, Böhmová M, Kuželová K, Hrdý J, Gašová Z, Vydra J, Dostálová Merkerová M, Hortová-Kohoutková M, Frič J   +19 more
doaj  

Prospects for immunotherapy of cancer: experience in experimental systems. [PDF]

, 1970
Peter Alexander
openalex   +1 more source

PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasion

Cancer Cell International
Background Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays an important role in diverse cellular processes by regulating Rho guanosine triphosphate (GTP)ases activity. RhoGDI1 phosphorylation regulates the spatiotemporal activation of Rho
Jeewon Lim, Yo Sep Hwang, Hyang Ran Yoon, Jiyun Yoo, Suk Ran Yoon, Haiyoung Jung, Hee Jun Cho, Hee Gu Lee   +7 more
doaj   +1 more source

A phase I study of active specific intralymphatic immunotherapy (ASILI) [PDF]

, 1978
Guy Juillard, Pamela Boyer, Charles H. Yamashiro   +2 more
openalex   +1 more source

Characterization of alternative sPD-1 isoforms reveals that ECD sPD-1 signature predicts an efficient antitumor response

Communications Biology
Soluble PD-1 is a dissociated form of membrane PD-1 broadly present in cancer, infections, or autoimmune diseases. However, the clinical significance of sPD-1 remains controversial due to the uncertainty of its isoforms, origin, and production mechanism.
Ping Hou, Li Hu, Junrong Zhang, Xiaoyan Zhou, Yonglei Xiao, Lijun Li, Qiongwen Wu, Jing Liu, Yuhong Lin, Ling Chen   +9 more
doaj   +1 more source

Immunotherapy for mountain cedar pollinosis

, 1976
Hobert L. Pence, Don Q. Mitchell, Robert L. Greely, Bryan R. Updegraff, Hartley A. Selfridge   +4 more
openalex   +1 more source

Overcoming some Limiting Factors in Tumour Immunotherapy [PDF]

, 1973
Omar Fakhri, J R Hobbs
openalex   +1 more source